Recent Funding
Companies
Jnana Therapeutics

Jnana Therapeutics

Unlocking the full potential of chemoproteomics to accelerate the discovery of new small molecules that can change the course of disease.

Health and bio Education

Latest funding

$107M Series B+ · November 15, 2022

Led by Bain Capital Life Sciences · Source: PR Newswire

Total raised: $207M across 3 sourced rounds

All 3 rounds ↓

Website: jnanatx.com.

X: @jnanatx · 494 followers.

LinkedIn: linkedin.com.

Categories: Health and bio Education.

Sectors: Biotechnology, Health Care, Medical, Therapeutics.

Stage: Series B+.

Based in: Boston, United States.

Founded: 2016.

Total raised: $207M in 3 sourced rounds.

Last round: Nov 15, 2022 · 1,458 days ago.

Headcount: 51–100 employees.

On Recent Funding since: Nov 8, 2026.

Signals

X account@jnanatx · created Dec 14, 2017 (8 years old) · 494 followers

Website registeredMar 11, 2017 (9 years old)

TIMELINE · MONEY RAISED

Jnana Therapeutics | 278 days from website to first raise on record

@jnanatx·Raised $207M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

November 15, 2022
Series B+ · $107M
BBain Capital Life Sciences (lead), AAbbVie, AAvalon Ventures, PPfizer Venture Investments, PPolaris, RRA Capital Management, VVersant Ventures
Source: PR Newswire
August 18, 2021
Series B+ · $50M
RRA Capital Management (lead), AAbbVie, AAvalon Ventures, PPfizer Venture Investments, PPolaris, VVersant Ventures
Source: businesswire.com
December 14, 2017
Series A · $50M
PPolaris (lead), AAbbVie, AAvalon Ventures, PPfizer R&D Innovate, VVersant Ventures
Source: boston.citybizlist.com
December 14, 2017
X account created
March 11, 2017
Website created

Founders and team

JK
Joanne Kotz Founder

LinkedIn
JB
Joel Barrish Founder

LinkedIn
JT
John Throup Founder

LinkedIn
GV
George Vratsanos Chief Medical Officer and Head of R&D
HS
Heather Smith Blanchette VP Nonclinical Development

Investors

Companies like Jnana Therapeutics

MMatchpoint Therapeutics$150M Series B+ · Oct 2026
AAtomwiseSeries B+ · Mar 2025
AAnaheim Bio$44.9M Series A · Nov 2026
EExcelsior Sciences$95M Series A · Dec 2025
IInductive Bio$25M Series A · May 2025
IIktos$16M Series A · Mar 2023

Other companies backed by Bain Capital Life Sciences

OOMass Therapeutics$310M Series B+ · Oct 2026
AAdvanCell$315M Series B+ · Jul 2026
AAngitia Bio$130M Series B+ · Feb 2026
SSyremis Therapeutics$165M Series A · Dec 2025
MMerida Biosciences$120M Series A · May 2025
CCardurion Pharmaceuticals$260M Series B+ · Jul 2024

Bain Capital Life Sciences portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/jnana-therapeutics (get a free API key).